Fauci predicts that the J&J vaccine will return this week in one way or another

Anthony FauciAnthony FauciDanger of discontinuing J&J vaccine on Sunday shows preview: Russia, US exchange sanctions increase police tensions; CDC ongoing vaccination campaign: Half of US adults receive at least one dose of COVID-19 vaccine MORE, President BidenJoe Biden The FedEx shooting suspect used two assault rifles he legally bought: US and Chinese police say they are “committed” to cooperating in climate change DC goes to dogs – Major and Champ, meaning MOREThe chief medical adviser on Sunday said he believes the Johnson & Johnson COVID-19 vaccine will return this week in one way or another after it was discontinued due to concerns about a possible connection to rare blood clots.

Defending CNN’s “State of the Union,” Fauci said he believed the vaccine administration would “get back on track” by Friday.

Host Dana BashGov. Dana BashArkansas says Trump’s “divisive” attacks on GOP officials are “useless.” Biden’s first press was not about him – not even Blinken suggests the US will not take punitive action against China over COVID-19 MORE noted that counselors from the Centers for Disease Control and Prevention (CDC) are scheduled to meet Friday and asked Fauci if a decision would be made during that meeting.

“Well, I think until then we will make a decision. Now, I don’t want to go before the CDC and the [Food and Drug Administration] and the advisory committee, but I would imagine that what we will see is that it will come back and come back in a kind of warning or restriction, “Fauci said.

“Again, I don’t know. I don’t want to be in front of them, but I’m always asked to do that. I think we’ll get it back in some way or form,” Fauci added. “I hope we don’t see anything extended beyond Friday. We have to make a decision one way or another on Friday.”

Johnson & Johnson was discontinued last week after officials noticed six blood clots in the nearly 7 million doses given in the United States. Many health officials expressed concern that discontinuation of the vaccine would fuel the vaccine’s hesitation.

.Source